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Abstract: Home Opioid Use Following Cesarean Delivery: How Many 
Opioid Tablets Should Obstetricians Prescribe? 
 
Aim: To quantify home opioid use after cesarean delivery and identify factors 
associated with increased opioid use.  
 
Methods: A convenience sample of women discharged by postoperative day 
two following a term cesarean delivery of a singleton fetus from May 2015-May 
2016 were contacted two weeks postpartum and questioned regarding opioid 
use, pain control, and pain expectations.  
 
Results: Among 141 women included in the analysis, the median number of 
opioid tablets used was 36 (interquartile range 16, 45) and the median number 
prescribed was 60 (interquartile range 42, 65). Logistic regression identified 
operative time ≥59.5 minutes and number of opioid tablets prescribed as two 
factors independently associated with opioid use in the top quartile.  
 
Conclusions: In the first two weeks postpartum, 75% of women used 45 or 
fewer opioid tablets. Operative time over one hour and increased number of 
opioid tablets prescribed are factors associated with higher postpartum opioid 
use. 
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Introduction  
According to the Centers for Disease Control (CDC), prescription opioid 
overdose death rates more than tripled from 1999 to 2008 (1.4 vs 4.8 persons 
per 100,000, respectively and 0.9 vs 3.7 female persons per 100,000, 
respectively).1 To address the rising concern regarding the opioid abuse 
“epidemic,” the CDC released an issue brief recommending that health care 
providers follow evidence-based guidelines for prescribing opioids.2  
 The most common indication for a patient’s initial opioid prescription is 
surgery.3 This is likely related to the fact that opioid-based therapy regimens are 
the most commonly used treatment for postoperative pain. With cesarean 
deliveries (CD) being the most commonly performed surgery in the United 
States,4 it is important that obstetric providers prescribe opioids in a safe and 
effective way. However, as there is currently limited data5 quantifying home 
opioid needs following CD, we have limited evidence on which to base our 
opioid prescribing practices—much less to establish evidence-based guidelines.  
A lack of guidelines regarding the average number of opioid tablets 
patients require following specific procedures or surgeries forces physicians to 
rely on their “best guess.” This subjective approach has led to over-prescribing 
in many surgical specialties, as detailed in dermatologic,6 orthopedic,6 urologic,7 
obstetric,5,8 and gynecologic literature.9 
Therefore, the primary aim of our study was to quantify the number of 
opioid tablets used by patients in the first two weeks following CD. A secondary 
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aim was to identify factors available at the time of patient discharge that are 
independently associated with increased opioid use. 
 
Methods  
We conducted a retrospective study using a convenience sample of 
women undergoing a CD at the University of Michigan Health System between 
May 2015 and May 2016. The study does not violate the policies and/or 
procedures established by the journal and received exempt status from the 
University of Michigan Institutional Review Board (HUM00098254). A list of 
patients who met study criteria were obtained from our departmental database 
every two weeks during the study period. Women were included if they were 
age 18 years old or greater and status post CD for a term, singleton gestation. 
Our aim was to survey a low-risk population of postpartum women. Exclusion 
criteria included: less than 37 weeks gestational age at delivery, multifetal 
gestation, intrauterine fetal death/still birth, or any other complications requiring 
the infant and/or patient to still be hospitalized at two weeks postpartum. 
Women were also excluded if they were discharged after postoperative day two, 
which is customarily the day of discharge following an uncomplicated CD at our 
institution.  
 An attempt was made to contact women by phone on postoperative day 
14, and if unsuccessful, three total attempts were made through postoperative 
day 16. Women were excluded if they were unable to be contacted after three 
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attempts. A research assistant using a script conducted the interviews. 
Interview questions used the term “narcotic” rather than “opioid,” as narcotics is 
deemed the term patients use and understand most.11 Consent was implied 
when women verbally agreed to participate. Women were given a verbal 
version of the Surgical Pain Scale, which assesses average pain on a scale of 
0-10 within the previous 24 hours during various levels of activity.10 Women 
were asked to specify the types of pain medications they were using and then 
count the number of narcotic tablets remaining from their original (or refilled) 
prescription. Women rated their overall pain control as poor, adequate, or good. 
They were also asked to rate their postoperative pain relative to what they 
expected their pain to be (much better than expected, better, about the same, 
worse, or much worse). Finally, they were asked about breastfeeding status. 
Chart review was then performed to obtain basic demographic, clinical, and 
peripartum data (including tobacco use, antepartum opioid use, and chronic 
pain—defined as a pre-pregnancy diagnosis of chronic pain, chronic back pain, 
migraines or chronic headaches, fibromyalgia, or temporomandibular joint pain). 
Data regarding the number of discharge opioids prescribed, as well as any 
opioid refills, were also obtained.  
 Our study group ultimately included women from two time periods over 
the course of the study: May through July 2015 and February through May 
2016. The reason for these two “cohorts” was that while analyzing data from the 
initial groups, the average number of opioid tablets being prescribed at 
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discharge had notably decreased. Therefore, we decided to collect data on a 
second group of women in 2016 to assess whether opioid prescribing practices 
had actually changed by virtue of our conducting the study.  
 Continuous data were tested for normality using histograms, as well as 
the Kolmogorov-Smirnov and Shapiro-Wilks tests. Bivariate analyses compared 
women whose opioid use was determined to be in the top quartile versus those 
in the bottom 75% in order to identify variables associated with increased opioid 
use. A similar comparison was done for women from the 2015 versus 2016 
cohorts. Normally distributed data were analyzed using Student’s t-test and 
nonparametric data were analyzed using Mann-Whitney U test. Categorical 
variables were analyzed using Chi-square or Fisher’s exact tests where 
appropriate. Given the trend toward significance with infant weight, and our 
hypothesis that a higher infant weight may be a marker for pre-CD labor, require 
larger incisions, and/or have a more traumatic delivery, a receiver operator 
characteristic (ROC) curve was generated and the maximal Youden’s index 
determined. The same was done for operative time. The optimal cut-off value 
for each was determined using Youden’s index.12 The area under the ROC 
curve (AUC) was calculated for infant weight and operative time as well, and 
was used as an index of diagnostic accuracy. Variables significant in bivariate 
analyses were used in a logistic regression model to identify factors 
independently associated with women in the top quartile for opioid usage. 
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Analyses were performed using IBM SPSS Statistics for Windows (Version 
21.0. Armonk, MY: IBM Corp.). 
 
Results 
One hundred and forty-one women met inclusion and exclusion criteria. 
Of those, 99 were contacted between May and July 2015 and 42 were 
contacted from February to May 2016.   
 Overall, subjects were 32.0 ± 4.9 years old (mean ± standard deviation) 
and had a BMI of 29.0 ± 6.3 kg/m2. One hundred and fourteen women were 
Caucasian (80.9%), 12 were African-American (8.5%), nine were Asian (6.4%), 
and six were of another race (4.2%). All of the study participants had low 
transverse incisions of both skin and uterus. Three women were discharged 
home on postpartum day one (two from the 2015 cohort and one from the 2016 
cohort) and the remaining 97.9% (138/141) were discharged home on 
postpartum day two. Sixteen subjects had postoperative complications: nine 
had wound infection/dehiscence (56.3%), three had preeclampsia (18.8%), two 
had endometritis (12.5%), one had mastitis (6.3%), and one had pyelonephritis 
(6.3%).  
The median number of opioid tablets used in the first two weeks post-CD 
was 36 (interquartile range (IQR) 16, 45) and the median number prescribed 
was 60 (IQR 42, 65). The distribution of opioid-containing analgesic medications 
prescribed was as follows: 84.4% (119/141) oxycodone 5 mg/acetaminophen 
This article is protected by copyright. All rights reserved.
Opioid Use Following Cesarean Delivery 9 
 
325 mg; 6.4% (9/141) oxycodone 5 mg; and 1.4% (2/141) hydrocodone 5 
mg/acetaminophen 325 mg. Overall, 94.3% (133/141) of women reported using 
ibuprofen. While 54.6% (77/141) of women reported receiving “enough” opioid 
tablets at the time of discharge, 31.9% (45/141) thought they were prescribed 
“too much” and 12.8% (18/141) stated their prescription was “not enough.” 
Seven percent (10/141) of women received an opioid refill. Nineteen percent 
(27/141) were still using opioids and 63.8% (90/138) were still using ibuprofen 
at two weeks postpartum.  
Women who used more than 45 opioid tablets were determined to be in 
the top quartile and, with the exception of parity, had similar demographic 
characteristics as those who used ≤45 tablets (Table 1). There were otherwise 
no statistically significant differences between the opioid use groups across 
demographic, peripartum, and postoperative variables. Ninety-eight percent of 
CD involved residents and the level of resident did not differ significantly 
between groups.   
 Women in the top quartile used more than double the number of opioids 
compared to women in the bottom 75% (60 vs 25 tablets, p<.001). Table 1 
shows a comparison of these two groups. Significant findings from this 
comparison showed that top quartile users were prescribed significantly more 
opioid tablets at discharge, were provided more opioid prescription refills, and 
reported continued use of opioid medications at two weeks postpartum, which 
was over three times the rate seen in women in the bottom 75%.  
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Overall, 97% of women reported pain control as good or adequate in 
both groups. Women in the top quartile reported higher pain scores at rest, 
during normal activities, and during the worst pain experienced on the day of 
the phone interview, as well as more frequently reporting their pain as “worse 
than expected.” Table 2 shows a comparison of pain scores and pain 
expectations between women in the top quartile and those in the bottom 75% 
for opioid use. 
The AUC for infant weight was 0.646 and the maximal Youden’s index 
was 0.272, corresponding to an optimal cut-off for infant weight of ≥3560 grams. 
For operative time, the AUC was 0.607 and the maximal Youden’s index was 
0.35, corresponding to an optimal cut-off of ≥ 59.5 minutes. Using the cut-off 
values of infant weight of ≥3560 grams and operative time ≥ 59.5 minutes in 
bivariate analyses (see methods section for AUC and Youden’s index 
calculations), women in the top quartile had a higher prevalence of infants 
weighing ≥3560 g (57.1% (20/35) vs 34.9% (37/106), p=.03) and operative time 
≥59.5 minutes (57.1% (20/35) vs 31.1% (33/106), p=.01). Table 3 shows the 
multivariable logistic regression performed using dichotomized infant weight and 
operative time, as well as variables significantly different from Table 1. 
Operative time ≥59.5 minutes and number of opioid tablets prescribed at 
discharge remained independently associated with opioid use in the top 
quartile. Pearson’s correlation between number of discharge opioids prescribed 
and number of opioids used was 0.45 (p<.001).  
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Data from the 99 women from 2015 and the 42 women from 2016 were 
then compared. Groups were similar for all demographic and perioperative 
variables except for parity (1 (1, 2) [median (IQR)] vs 1 (0, 1), respectively, 
p=.003) and indication for CD (more women in 2016 underwent a scheduled CD 
(73.8% (31/42) vs 53.5% (53/99), p=.03)). Figure 1 shows the comparison of 
number of opioids prescribed and patient opioid use between the 2015 and 
2016 cohorts. Women who underwent CD in 2016 received significantly fewer 
opioids at discharge and also used fewer opioids in the first two postpartum 
weeks. A smaller proportion of women from 2016 received an opioid 
prescription refill compared to those in 2015; however, this finding was not 
statistically significant (2.4% (1/42) vs 9.1% (9/99), p=.16). Additionally, pain 
scores and satisfaction with pain control were similar between the groups (data 
not shown).  
 
Discussion 
In this study of women two weeks following a term CD and discharged 
home by postpartum day two, 75% used 45 or fewer opioid tablets. On average, 
patients were prescribed 40% more opioids than they used. Factors 
independently associated with being in the top quartile for opioid use included 
operative time ≥59.5 minutes and increased number of discharge opioids 
prescribed. Over the course of the study, physicians decreased the number of 
discharge opioids prescribed and patients also used fewer. Variability in opioid 
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prescribing practices and differences in consumption following CD highlight the 
need to better understand prescription patterns, utilization by patients, and the 
potential impact of these practices. Identifying risk factors for increased 
postpartum opioid requirements may help physicians prescribe opioids more 
accurately and therefore reduce surplus. The two factors we identified to be 
independently associated with postpartum opioid use in the top quartile were 
operative time ≥59.5 minutes and number of opioids prescribed at discharge. 
We hypothesize that an increased operative time may be a marker of surgical 
difficulty or a result of additional planned or unplanned procedures. Surgical 
technique may also impact operative time as well, with shorter times associated 
with choosing not to close the peritoneum,13 blunt versus sharp abdominal 
entry,14 single versus double layer uterine closure,14 and no creation of a 
bladder flap.15 At our institution, surgical techniques used during CDs vary 
based on surgeon discretion and certain details may not be specified in the 
operative reports. Therefore, we were unable to determine the impact of 
variations in surgical technique on operative time in the current study.  
Number of discharge opioid tablets prescribed was the other factor 
predictive of women in the top quartile for opioid use. This is concordant with 
findings by Bateman et al., who showed that being prescribed more opioids at 
discharge was associated with consuming more opioids, independent of pain 
severity at discharge or other patient characteristics.5 Because our study design 
precludes our ability to assess causality, we are unable to state with certainty 
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why women who were prescribed more opioids used more—was it because 
more were available to use or because they were having more pain? Our 
finding, that women who underwent surgery in 2016 versus 2015 were 
prescribed significantly fewer discharge opioids and also used significantly 
fewer tablets, in conjunction with Bateman et al.’s findings, supports the first 
hypothesis.  
These groups were otherwise similar in terms of demographics, 
perioperative variables, and patient-reported pain measures. Therefore, our 
results suggest that physician prescribing patterns may influence utilization of 
opioid pain medications by patients. Although chronic pain diagnoses and 
preoperative opioid use have been shown in prior studies to increase 
postoperative pain medication requirements,5,16,17 the absolute numbers of 
women with these characteristics in our study were low; consequently, we were 
likely underpowered to detect these differences. 
Limitations of our study include the use of a relatively homogenous 
population collected via convenience sampling, which can be prone to selection 
bias and sampling errors. In an effort to minimize bias, we used a system-
generated list of women who met our study criteria and attempted to call all 
women on the list. We limited our study to a relatively low-risk population 
discharged by postoperative day two, so our results may not be generalizable to 
high-risk pregnancies or patients discharged on postoperative day three or 
more. We also do not know how many opioid pills patients used following the 
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first two postpartum weeks. Finally, our study was subject to “observed bias,” as 
physicians began prescribing fewer discharge opioids after data on the initial 
2015 cohort were collected. However, we feel that our study was actually 
strengthened by incorporation of data on the second cohort of women in 2016, 
as it reflects actual clinical practice. 
 This study also has several strengths. First, we present a simple yet 
effective method for quantifying home opioid use following surgery, and recall 
bias was limited because the phone interview was within two weeks of surgery. 
Second, we assessed patient pain using the Surgical Pain Scale, which in 
written form is a validated measurement tool. Third, to our knowledge this is the 
first study quantifying opioid use after hospital discharge following CD.  
In summary, our findings suggest that a discharge prescription of 45 
opioid tablets following a term CD for patients discharged on postoperative day 
one or two is acceptable for the majority of women. Operative time exceeding 
one hour is a risk factor for using a greater number of opioid tablets. Larger 
studies will be necessary to identify other patient-level modifiers that may 
impact postoperative opioid utilization. Ultimately, these data could serve as a 
reference for developing evidence-based guidelines for opioid prescribing 
following cesarean delivery. 
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Figure Legend 
Figure 1. Changes in Number of Discharge Opioid Tablets Prescribed 
Following Cesarean Delivery and Patient Opioid Use Over the Study 
Period 
*Comparison of number of opioid tablets prescribed between 2015 and 2016. 
**Comparison of number of opioid tablets used by patients between 2015 and 
2016. 
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Table 1. Demographics, perioperative variables, and two-week postoperative 
opioid use for women who underwent cesarean delivery 
Demographics and Perioperative 
Variables 
 







Age, years 31.9 ± 4.7 32.2 ± 5.6 .70 
Parity 1 (0, 2) 1 (0,1) .04 
BMI, kg/m2 28.8 ± 6.5 29.7 ± 5.3 .48 
Race/Ethnicity   0.73 
      Caucasian   83 (78.3) 31 (88.6) -- 
      Asian 8 (7.5) 1 (2.9) -- 
      African American 9.4 (10) 5.7 (2) -- 
      Hispanic 2 (1.9) 0 (0) -- 
      Other/Unknown  3 (2.8) 1 (2.9)  
Tobacco User 9 (8.5) 5.7 (2) .60 
Cesarean Delivery‡   .59 
        Primary  45 (42.5) 19 (54.3) -- 
        Repeat  61 (57.5) 16 (45.7) -- 
Chronic Pain Diagnosis§ 7 (6.6) 3 (8.6) .71 
Antepartum Opioid Use 2 (1.9) 0 (0.0) >.99 
Gestational Age, weeks 39.3 (39.0, 39.9) 39.1 (38.6, 40.3) .63 
Infant Weight, grams 3495.70 ± 487.5 3683.4 ± 538.6 .06 
Indication for Cesarean Delivery   .11 
       Scheduled/planned 67 (63.2) 17 (48.6) -- 
       Arrest of descent 18 (17.0) 5 (14.3) -- 
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       Arrest of dilation 5 (4.7) 7 (20.0) -- 
       Fetal indication 16 (15.1) 6 (17.1) -- 
Labored prior to Cesarean Delivery 25 (23.9) 11 (31.4) .36 
Length of active second stage, minutes  602.6 ± 337.0 681.8 ± 339.7 .64 
Operative Time, minutes 56.1 ± 17.9 60.7 ± 20.0 .20 
Skin Closure   .41 
       Staples 11 (10.4) 2 (5.7) -- 
       Suture 95 (89.6) 33 (94.3) -- 
Estimated Blood Loss, mL 800 (800, 1,000) 850 (800, 1,000) .15 
Opioids Tablets Prescribed at Discharge 50 (40, 60) 60 (60, 70) <.001 
At Two Weeks Postpartum    
Opioids Tablets Used 25 (12, 39) 60 (54, 66) <.001 
Received a Opioid Refill 3 (2.8) 7 (20.0) .001 
Still Using Opioids 13 (12.3) 14 (40.0) <.001 
Still Using Ibuprofen 60 (56.6) 30 (85.7) .003 
Breastfeeding 88 (83.0) 29 (82.9) .98 
Postoperative complication  13 (12.3) 3 (8.6) .76 
† Data presented as mean ± SD, median (IQR) or n (%). P values calculated using Chi-Square, Fisher’s 
exact test, student’s t test, or Mann-Whitney U. If data are normally distributed, they are reported using 
mean +/- SD.  
‡ Two cesarean deliveries were done with two attendings and one with an attending and a fellow 
§ Defined as pre-pregnancy diagnosis of chronic pain, chronic back pain, migraines or chronic headaches, 
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Table 2. Pain scores and expectations for women who underwent a cesarean 
delivery 
Pain Scores and Expectations 




(N=35) P value 
Surgical Pain Scale Scores Two Weeks Postoperatively  
(0=no pain, 10=worst pain imaginable) 
What was the average amount 
of pain you had when you were 
at rest? 
0 (0, 2.0) 1.5 (1, 3) .018 
How much pain did you have 
during your normal activities (for 
example walking, climbing stairs, 
driving a car, getting up from a 
chair)? 
1 (1, 3) 3 (1, 5) .002 
How much pain did you have 
when you were exercising, doing 
strenuous work, or lifting objects 
you used to be able to lift 
comfortably? 
2 (1, 3) 
(N=59) 
2 (2, 4.5) 
(N=14) 
.395 
How unpleasant or disturbing 
was the worst pain that you had 
today? 1 (0, 3) 3.5 (1, 5.25) .002 
Overall Rating of Postpartum Pain Control Two Weeks 
Postoperatively 
.11 
Poor 3 (2.8) 1 (2.9)  
Adequate 24 (22.6)  13 (37.1)  
Good 79 (74.5) 21 (60.0)  
Postpartum Pain versus Expectation Two Weeks Postoperatively .02 
Much Worse Than Expected 3 (2.8) 0 (0.0)  
Worse Than Expected 13 (12.3) 10 (28.6)  
About What Expected 41 (38.7) 13 (37.1)  
Better Than Expected 23 (21.7) 12 (34.3)  
Much Better Than Expected 26 (24.5) 0 (0.0)  
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Table 3. Factors available at discharge and associated with women in the top 













Constant -- 0.01 -- -4.96 1.13 <.001 
Parity 0.58 0.63 0.37–1.08 -0.46 0.27 .09 
Infant Weight ≥3560 
grams 2.49 2.27 0.95–5.43 0.82 0.44 .06 
Operative Time  
≥59.5 minutes 2.95 2.70 1.12–6.53 0.99 0.45 .03 
Number of Opioid 
Tablets Prescribed 
at Discharge 
1.07 1.06 1.03–1.10 0.06 0.02 <.001 
† Logistic regression performed including variables significant in bivariate analyses for women in the top 
quartile of postpartum opioid use. 
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